574 results
·
17ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Eu Ivd General
×
GlucoSure POC
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·No longer on the market
KETOSURE POC
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·On the market
KETOSURE POC
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·On the market
KETOSURE POC
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·On the market
KETOSURE POC
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·On the market·1 country
GlucoSure POC Compact
Device
EU IVDD
·
Eu Ivd General
·Apex Biotechnology Corp.·No longer on the market
CRP Control POC
Device
EU IVDD
·
Eu Ivd General
·Labquality Oy·No longer on the market
CANNABINOIDS - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
OPIATES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
OPIATES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
BENZODIAZEPINES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
AMPHETAMINES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
AMPHETAMINES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
CANNABINOIDS - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
PHENCYCLIDINE - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
OPIATES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
OPIATES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
BENZODIAZEPINES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
BENZODIAZEPINES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market
BARBITURATES - RT & POC
Device
EU IVDD
·
Eu Ivd General
·Abon Biopharm(Hangzhou) Co., Ltd·On the market